These final results, together with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 help the thought of targeting ACKR3 as a novel way to modulate the opioid method, which could open new therapeutic avenues for opioid-similar Problems. Sometimes I get a slight https://lemmyb813dbw3.bloggactif.com/profile